Mode of delivery and characterization of porcine iPSCs | [8] | [10] | [9] | [11] | [70] | [68] | [71] | [74] * | [74] # | |
Delivery method | Viral | Viral | Viral | Viral | Plasmid | Viral | Viral | Viral | Viral | |
Pluripotency markers | Oct4 | ND | + | + | + | + | + | + | + | + |
Sox2 | + | + | + | + | + | + | + | + | + | |
Nanog | + | + | + | + | + | + | + | + | + | |
Rex1 | + | + | + | ND | + | ND | ND | ND | + | |
CDH1 | ND | + | + | ND | ND | ND | ND | ND | + | |
Surface markers | SSEA1 | ND | + | − | + | − | + | ND | − | − |
SSEA3 | ND | − | + | + | − | − | ND | ND | ND | |
SSEA4 | + | − | + | − | + | + | + | + | − | |
Tra-1-60 | ND | ± | + | + | + | ND | + | ND | ND | |
Tra-1-81 | ND | − | + | − | − | ND | + | ND | ND | |
Functional assays | Teratoma | + | + | + | + | ND | + | + | − | − |
EBs | ND | + | + | + | + | + | + | + | + | |
Chimera | ND | ND | ND | + | ND | ND | ND | ND | ND |